Generics

Camber's generic Norco is indicated to relieve moderate-to-severe pain.

Lupin is introducing generic Anafranil, which has a market value of roughly $6.2 million.

Dr. Reddy's has brought Marc Kikuchi onboard from Zydus Pharmaceuticals, naming him CEO, North America generics.

USP's Generics Access Plan intends to facilitate generics competition by collaborating with the Food and Drug Administration to develop and revise quality standards.

Mylan’s generic Advair Diskus is the first generic drug product approved for one of the most commonly prescribed asthma and COPD inhalers.

The FDA is continuing its push to increase development and approval of generics and biosimilars.

Fresenius Kabi's leucovorin calcium injection is the only liquid presentation of leucovorin available.

Hikma has introduced mitomycin for injection, a cancer treatment that had a market value of roughly $43 million for the year ended November 2018, according to IQVIA data.